These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2826599)

  • 1. Conditioned augmentation of natural killer cell activity. Independence from nociceptive effects and dependence on interferon-beta.
    Solvason HB; Ghanta VK; Hiramoto RN
    J Immunol; 1988 Jan; 140(2):661-5. PubMed ID: 2826599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioned enhancement of natural killer cell activity, but not interferon, with camphor or saccharin-LiCl conditioned stimulus.
    Ghanta VK; Hiramoto NS; Solvason HB; Tyring SK; Spector NH; Hiramoto RN
    J Neurosci Res; 1987; 18(1):10-5. PubMed ID: 2824798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of natural immunity (NK activity) by conditioning.
    Hiramoto RN; Hiramoto NS; Solvason HB; Ghanta VK
    Ann N Y Acad Sci; 1987; 496():545-52. PubMed ID: 3037977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of natural killer cell activity and interferon production by manganese in young mice.
    Smialowicz RJ; Riddle MM; Rogers RR; Luebke RW; Burleson GR
    Immunopharmacol Immunotoxicol; 1988; 10(1):93-107. PubMed ID: 2452180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone blocks the expression of the conditioned elevation of natural killer cell activity in BALB/c mice.
    Solvason HB; Hiramoto RN; Ghanta VK
    Brain Behav Immun; 1989 Sep; 3(3):247-62. PubMed ID: 2482096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renewal of natural killer cells in mice having elevated natural killer cell activity.
    Nassiry L; Miller SC
    Nat Immun Cell Growth Regul; 1987; 6(5):250-9. PubMed ID: 3444438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A behavioral augmentation of natural immunity: odor specificity supports a Pavlovian conditioning model.
    Solvason HB; Ghanta VK; Lorden JF; Soong SJ; Hiramoto RN
    Int J Neurosci; 1991 Dec; 61(3-4):277-88. PubMed ID: 1824390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
    Kalland T; Alm G; Stålhandshe T
    J Immunol; 1985 Jun; 134(6):3956-61. PubMed ID: 2580900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory activity of low doses of interferon alpha,beta in mice.
    Daurat V; Dorfman P; Bastide M
    Biomed Pharmacother; 1988; 42(3):197-206. PubMed ID: 3263148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
    Mandler RN; Biddison WE; Mandler R; Serrate SA
    J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The direction of the conditioned natural killer cell response can be re-directed with indomethacin and/or handling.
    Rogers C; Ghanta V; Hsueh CM; Hiramoto N; Hiramoto R
    Int J Neurosci; 1992; 67(1-4):229-39. PubMed ID: 1305636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production.
    Handa K; Suzuki R; Matsui H; Shimizu Y; Kumagai K
    J Immunol; 1983 Feb; 130(2):988-92. PubMed ID: 6294182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Backward conditioning of tumor necrosis factor-α in a single trial: changing intervals between exposures to lipopolysaccharide and saccharin taste.
    Washio Y; Hayes LJ; Hunter KW; Pritchard JK
    Physiol Behav; 2011 Feb; 102(2):239-44. PubMed ID: 21081136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-methylcholanthrene: transient inhibition of the lytic step of mouse natural killer cells.
    Kalland T; Forsberg JG
    J Natl Cancer Inst; 1983 Aug; 71(2):385-90. PubMed ID: 6576196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
    Gorelik E
    Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.